Frontlight ResearchEarly access
Trial site
Dana Faber Cancer Institute
- 3running trials
- 1closed trial
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Prostate cancer2 trials
- Childhood cancers1 trial
- Chronic myeloid leukaemia1 trial
- Colorectal cancer1 trial
- Endometrial cancer1 trial
- Head and neck cancer1 trial
- Lung cancer1 trial
- Ovarian cancer1 trial
- Phase
- Phase 22 trials
- Phase 11 trial
- Phase 31 trial
- Status
- Active, not recruiting1 trial
- Completed1 trial
- Not yet recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Bristol-Myers Squibb1 trial
- Corbus Pharmaceuticals Inc.1 trial
- IDEAYA Biosciences1 trial
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1 trial
Running trials
Recruiting
Active, not recruiting
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
Recruiting
Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Head and neck cancer1 recruiting
- Prostate cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026